chapter 13. gene diagnosis - shandong university
TRANSCRIPT
To identify the cause of a disease or condition based on gene analysis or test.
Methods of diagnosing a genetic disease:
1) Direct diagnosis: detect disease-causing mutation
2) Indirect diagnosis: tracking the disease gene by linkage analysis
1. Direct diagnosis
Premise: for the known gene mutations 1.1 Point mutation (without size change)
Restriction site altered by mutation PCR-RFLP
No restriction site altered by mutation Allele specific oligonucleotide (ASO )
1.2 Insertion or deletion (with size change)large fragments – by Southernsmall fragments – by PCR
1.3 DNA Sequencing
1.1.1 Detect point mutation by PCR-RFLP
sickle cell anemia:又称Hb S病
1949 Pauling HbS
SA1956 Ingram :β-globin codon 6: Glu→Val
CCT GAG GAG … (Hb bA)
… CCT GTG GAG … (Hb bS)
Hb bA
Hb bS
MstII MstII MstII
Glu
Val
… CCT GAG GAG … (Hb bA)… CCT GTG GAG … (Hb bS)
CCT NAG G (MstII)
1.15 kb
1.35 kb
Southern blotting
PCR-RFLP Steps:
Amplify region of β-globin around codon 6
Cut with MstII
Run products on gel
Genotype analysis
1.1.2 Detect point mutation by ASO
normal allele probe: 5′TCCATTAACAGTAAGTAATTT3′mutant allele probe: 5′TCCATTAACAATAAGTAATTTT3′
S1 S2 S3 S4 S5 S6
S1 S2 S3 S4 S5 S6
Probe a
Probe A
Aa Aa aa aaAA AA
1. Direct diagnosis
Premise: for the known gene mutations 1.1 Point mutation (without size change)
Restriction site altered by mutation PCR-RFLP
No restriction site altered by mutation Allele specific oligonucleotide (ASO )
1.2 Insertion or deletion (with size change)large fragments – by Southernsmall fragments – by PCR
Hemoglobinopathies
Structurally abnormal hemoglobin chains
Thalassemias
Abnormal production of normal chains
Hemoglobinopathies
Qualitative structural abnormalities of globin polypeptide chains
Hemoglobin variants due to: single base pair substitution Stop codon muatation Framshift mutation Codon insertion or deletion Fusion gene
Thalassemias
Decreased chain production
Decreased mRNA production
Beta thalassemia - decreased beta chains
Alpha thalassemia - decreased alpha chains
• Normal /
• Silent carrier - /
• Minor -/-
--/
• Hb H disease --/-
• Barts hydrops fetalis --/--
Alpha Thalassemia
Beta Thalassemia
Decreased Beta chain production
B+ - decreased synthesis
Bo - absent synthesis
Homozygous condition provides a wide range of disease and heterozygous condition can range from mild to moderately severe
1.2.1 Detect size change by Southern blot
5’ 3’16pz yz y 2 1
5’ 3’16pz yz y 2 1
a-thalassanemia (a-globin chains are deficient)
a2 a1
hydrops fetalis (fetal or early neonatal death)
Hb H disease (mild to severe anemia)
a1-thalassemia (no significant anemia)
a2-thalassemia (silent carrier state)
normal
Alpha Thalassemia
aA/a+
aA/a0 or
a+/a+
a+/a0
a0/a0
Genomic DNA Bam HI DNA fragmentselectrophoresis
Size fraction transfer DNA fragments on membrane Hybridizing
14kb
10kb
AA Aa aa
Duchenne Muscular Dystrophy
17 18 19 44 45 46 47 48 49
17
19
44
45
48
C P1 P2 P3 P4Patient1: exon 44 deleted
Patient2: exon 17deleted
Patient4: exon 19 deleted
Patient3: exon 45 deleted
1.2.2 Detect size change by PCR
2. Indirect diagnosis
Demonstration of a mutation in known gene
Demonstration of a disease allele of unknown genes by using tightly linked markers to the disease gene
2.1 detect a mutation in a known gene
Hemophilia A
1 1/2
2 1/1 2 1/2 2 1
XAXa
XaY XaY
XAY
XAY XAYXAXA XAXa
Ⅰ
Ⅱ1
2
2
1
1
3 4 5 6
Ⅲ 2/2
1/2
1
2
XAY
XaY
XAXA
XAXa
Disease gene
Marker 1 Marker 2
2/5
P
Ⅰ
Ⅱ1
2
2
1
1
3 4 5 6
Ⅲ
2/4 3/5
2/3 4/5 2/5 3/4 4/52/5
2
2/4
P
3/5
N
3/4
N
2/2 P
2/5 ?
5/5 N
2.2 detect a mutation in an unknown gene (mapped disease gene)
Aa aa
Aa Aa aa aa
Indirect Gene Diagnosis
M1 1 23 2 2 4 4 12 2
XAY XAXa
XaY
XaY XAY XaY
? ?
Disease gene
Marker 1
Recombination ?
Exercise
Ⅰ
Ⅱ
Ⅲ1
1
1 2
2
2 3
3 4
4
5 6
3/5 2/6
5/6 2/5 2/5 2/3 1/61/4
1/5 1/6 2/5 1/2
Aa aa
aa Aa Aa aa aa aa
aaaaAaAa aa